Automated High-Quality Insights
Meet Galen™, the most widely-deployed AI-powered platform in pathology.
Developed by pathologists for pathologists, Galen is a clinical-grade, multi-tissue platform that helps pathologists detect and grade breast, prostate and gastric cancer, along with more than a hundred other clinically relevant features.
Seamlessly integrated with third party digital pathology software solutions, scanning platforms and laboratory information systems, Galen’s AI-enabled workflows deliver automated high-quality insights that enhance patient safety, increase physician confidence and boost productivity.
Galen serves the world’s leading physicians, health systems and diagnostic service providers. The platform has demonstrated outstanding outcomes in rigorous worldwide clinical studies on multiple scanning systems and staining platforms.
Pathologists
- Enhanced diagnostic quality
- Faster results
- Better patient outcomes
- Greater confidence
- Lower workload
- Streamlined work experience
Patients
- Improved diagnostic quality
- Faster results
- Better clinical outcomes
- Greater confidence
Providers
- Better patient outcomes
- Higher productivity
- More efficient workflows
- Improved service quality
- Greater physician satisfaction
- Innovative positioning
Industry Partners
- The broadest AI platform
- Field-proven technology
- Validated performance
- Open API for seamless integration
Podcasts
IBEX’s daphna laifenfeld on AI-powered cancer diagnostics, company raising $38 million in series B funding and the future of personalised medicine
Articles
IBEX’s daphna laifenfeld on AI-powered cancer diagnostics, company raising $38 million in series B funding and the future of personalised medicine
The Galen platform is not cleared by the FDA and for Research Use Only (RUO) in the United States. Galen Breast and Galen Prostate are CE marked and approved in additional territories. Contact us for more information